EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...
Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease ...
EU drugs regulator recommends Alzheimer's drug from Eisai-Biogen
The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...
European watchdog partially approves new Alzheimer's drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...
Nasal Spray Could Delay Alzheimer's by Years
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
MedPage Today on MSN1d
Alzheimer's Researcher Placed on Leave; War on Drug Recovery; Lax Coroner Oversight
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Berislav Zlokovic, MD, PhD, a prominent ...
STAT19h
Mild Alzheimer’s patients won’t save Cassava Sciences
As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it ...
STAT1h
Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved
Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...
Medscape1h
Infection Plus Pollution Equals Increased Alzheimer’s Risk
The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...
Is Alzheimer’s Disease the new ‘Type 3’ diabetes?
Because November is Diabetes and Alzheimer’s awareness month, we are learning about the link between brain health and insulin ...
Pharmaceutical Technology37m
EMA rethinks stance, committee now recommends Leqembi for Alzheimer’s disease
The EMA’s Committee for Medicinal Products for Human Use has issued a positive recommendation for Eisai and Biogen’s Leqembi ...
The Highland County Press1d
Alzheimer’s Association encourages dementia caregivers to make their health and wellbeing a priority
During National Family Caregivers Month in November, the Alzheimer’s Association is encouraging dementia caregivers to make their own health an equal priority as they navigate the demands and stresses ...